| Semaglutide lowers body weight in rodents via distributed neural pathways S Gabery, CG Salinas, SJ Paulsen, J Ahnfelt-Rønne, T Alanentalo, ... JCI insight 5 (6), 2020 | 310 | 2020 |
| Eating and hypothalamus changes in behavioral‐variant frontotemporal dementia O Piguet, Å Petersén, B Yin Ka Lam, S Gabery, K Murphy, JR Hodges, ... Annals of neurology 69 (2), 312-319, 2011 | 223 | 2011 |
| Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses S Gabery, K Murphy, K Schultz, CT Loy, E McCusker, D Kirik, G Halliday, ... Acta neuropathologica 120, 777-788, 2010 | 117 | 2010 |
| Integrated brain atlas for unbiased mapping of nervous system effects following liraglutide treatment CBG Salinas, TTH Lu, S Gabery, K Marstal, T Alanentalo, AJ Mercer, ... Scientific Reports 8 (1), 10310, 2018 | 72 | 2018 |
| Hypothalamic and limbic system changes in Huntington's disease Å Petersén, S Gabery Journal of Huntington's disease 1 (1), 5-16, 2012 | 56 | 2012 |
| Volumetric analysis of the hypothalamus in huntington disease using 3T MRI: The IMAGE-HD study S Gabery, N Georgiou-Karistianis, SH Lundh, RY Cheong, A Churchyard, ... PloS one 10 (2), e0117593, 2015 | 46 | 2015 |
| Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis S Gabery, RM Ahmed, J Caga, MC Kiernan, GM Halliday, Å Petersén Neuropathology and Applied Neurobiology 47 (7), 979-989, 2021 | 37 | 2021 |
| Subjective sleep problems in Huntington's disease: a pilot investigation of the relationship to brain structure, neurocognitive, and neuropsychiatric function CR Baker, JC Stout, S Gabery, A Churchyard, P Chua, GF Egan, ... Journal of the neurological sciences 364, 148-153, 2016 | 37 | 2016 |
| Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial VR Aroda, J Aberle, L Bardtrum, E Christiansen, FK Knop, S Gabery, ... The Lancet 402 (10403), 693-704, 2023 | 33 | 2023 |
| SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease B Baldo, S Gabery, R Soylu‐Kucharz, RY Cheong, JB Henningsen, ... Neuropathology and applied neurobiology 45 (4), 361-379, 2019 | 32 | 2019 |
| Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: a case study. S Gabery, G Halliday, D Kirik, E Englund, Å Petersén Neuropathology & Applied Neurobiology 41 (6), 2015 | 32 | 2015 |
| The role of hypothalamic pathology for non-motor features of Huntington’s disease RY Cheong, S Gabery, Å Petersén Journal of Huntington's disease 8 (4), 375-391, 2019 | 31 | 2019 |
| Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity S Fjalldal, C Follin, S Gabery, PC Sundgren, IM Björkman-Burtscher, ... International Journal of Obesity 43 (3), 533-544, 2019 | 27 | 2019 |
| Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma S Fjalldal, C Follin, D Svärd, L Rylander, S Gabery, Å Petersén, ... European Journal of Endocrinology 178 (6), 577-587, 2018 | 27 | 2018 |
| Associations between metabolic risk factors and the hypothalamic volume in childhood leukemia survivors treated with cranial radiotherapy C Follin, S Gabery, Å Petersén, PC Sundgren, I Björkman-Burtcher, J Lätt, ... PLoS One 11 (1), e0147575, 2016 | 25 | 2016 |
| Early white matter pathology in the fornix of the limbic system in Huntington disease S Gabery, JE Kwa, RY Cheong, B Baldo, C Ferrari Bardile, B Tan, ... Acta neuropathologica 142 (5), 791-806, 2021 | 17 | 2021 |
| Characterization of a rat model of Huntington’s disease based on targeted expression of mutant huntingtin in the forebrain using adeno‐associated viral vectors S Gabery, MU Sajjad, S Hult, R Soylu, D Kirik, Å Petersén European Journal of Neuroscience 36 (6), 2789-2800, 2012 | 16 | 2012 |
| Microstructure alterations in the hypothalamus in cranially radiated childhood leukaemia survivors but not in craniopharyngioma patients unaffected by hypothalamic damage C Follin, S Fjalldal, D Svärd, D van Westen, S Gabery, Å Petersén, J Lätt, ... Clinical endocrinology 87 (4), 359-366, 2017 | 12 | 2017 |
| Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight 5 (6) S Gabery, CG Salinas, SJ Paulsen, J Ahnfelt-Ronne, T Alanentalo, ... | 8 | 2020 |
| Brain white matter lesions are associated with reduced hypothalamic volume and cranial radiotherapy in childhood‐onset craniopharyngioma S Fjalldal, L Rylander, D van Westen, H Holmer, C Follin, S Gabery, ... Clinical Endocrinology 94 (1), 48-57, 2021 | 3 | 2021 |
